Radiofrequency ablation of lung malignancies: Where do we stand?

Riccardo Lencioni, Laura Crocetti, Roberto Cioni, Alfredo Mussi, Gabriella Fontanini, Marcello Ambrogi, Chiara Franchini, Dania Cioni, Olivia Fanucchi, Raffaello Gemignani, Rubia Baldassarri, Carlo Alberto Angeletti, Carlo Bartolozzi

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Percutaneous radiofrequency (RF) ablation is a minimally invasive technique used to treat solid tumors. Because of its ability to produce large volumes of coagulation necrosis in a controlled fashion, this technique has gained acceptance as a viable therapeutic option for unresectable liver malignancies. Recently, investigation has been focused on the clinical application of RF ablation in the treatment of lung malignancies. In theory, lung tumors are well suited to RF ablation because the surrounding air in adjacent normal parenchyma provides an insulating effect, thus facilitating energy concentration within the tumor tissue. Experimental studies in rabbits have confirmed that lung RF ablation can be safely and effectively performed via a percutaneous, transthoracic approach, and have prompted the start of clinical investigation. Pilot clinical studies have shown that RF ablation enables successful treatment of relatively small lung malignancies with a high rate of complete response and acceptable morbidity, and have suggested that the technique could represent a viable alternate or complementary treatment method for patients with non-small cell lung cancer or lung metastases of favorable histotypes who are not candidates for surgical resection. This article gives an overview of lung RF ablation, discussing experimental animal findings, rationale for clinical application, technique and methodology, clinical results, and complications.

Original languageEnglish (US)
Pages (from-to)581-590
Number of pages10
JournalCardioVascular and Interventional Radiology
Volume27
Issue number6
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

Lung
Neoplasms
Therapeutics
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Necrosis
Air
Neoplasm Metastasis
Rabbits
Morbidity
Liver

Keywords

  • Lung neoplasms
  • Lung neoplasms, metastases
  • Lung neoplasms, therapy
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Lencioni, R., Crocetti, L., Cioni, R., Mussi, A., Fontanini, G., Ambrogi, M., ... Bartolozzi, C. (2004). Radiofrequency ablation of lung malignancies: Where do we stand? CardioVascular and Interventional Radiology, 27(6), 581-590. https://doi.org/10.1007/s00270-004-0008-6

Radiofrequency ablation of lung malignancies : Where do we stand? / Lencioni, Riccardo; Crocetti, Laura; Cioni, Roberto; Mussi, Alfredo; Fontanini, Gabriella; Ambrogi, Marcello; Franchini, Chiara; Cioni, Dania; Fanucchi, Olivia; Gemignani, Raffaello; Baldassarri, Rubia; Angeletti, Carlo Alberto; Bartolozzi, Carlo.

In: CardioVascular and Interventional Radiology, Vol. 27, No. 6, 11.2004, p. 581-590.

Research output: Contribution to journalArticle

Lencioni, R, Crocetti, L, Cioni, R, Mussi, A, Fontanini, G, Ambrogi, M, Franchini, C, Cioni, D, Fanucchi, O, Gemignani, R, Baldassarri, R, Angeletti, CA & Bartolozzi, C 2004, 'Radiofrequency ablation of lung malignancies: Where do we stand?', CardioVascular and Interventional Radiology, vol. 27, no. 6, pp. 581-590. https://doi.org/10.1007/s00270-004-0008-6
Lencioni R, Crocetti L, Cioni R, Mussi A, Fontanini G, Ambrogi M et al. Radiofrequency ablation of lung malignancies: Where do we stand? CardioVascular and Interventional Radiology. 2004 Nov;27(6):581-590. https://doi.org/10.1007/s00270-004-0008-6
Lencioni, Riccardo ; Crocetti, Laura ; Cioni, Roberto ; Mussi, Alfredo ; Fontanini, Gabriella ; Ambrogi, Marcello ; Franchini, Chiara ; Cioni, Dania ; Fanucchi, Olivia ; Gemignani, Raffaello ; Baldassarri, Rubia ; Angeletti, Carlo Alberto ; Bartolozzi, Carlo. / Radiofrequency ablation of lung malignancies : Where do we stand?. In: CardioVascular and Interventional Radiology. 2004 ; Vol. 27, No. 6. pp. 581-590.
@article{501f0c8b9df449d9baea84ca2da267d1,
title = "Radiofrequency ablation of lung malignancies: Where do we stand?",
abstract = "Percutaneous radiofrequency (RF) ablation is a minimally invasive technique used to treat solid tumors. Because of its ability to produce large volumes of coagulation necrosis in a controlled fashion, this technique has gained acceptance as a viable therapeutic option for unresectable liver malignancies. Recently, investigation has been focused on the clinical application of RF ablation in the treatment of lung malignancies. In theory, lung tumors are well suited to RF ablation because the surrounding air in adjacent normal parenchyma provides an insulating effect, thus facilitating energy concentration within the tumor tissue. Experimental studies in rabbits have confirmed that lung RF ablation can be safely and effectively performed via a percutaneous, transthoracic approach, and have prompted the start of clinical investigation. Pilot clinical studies have shown that RF ablation enables successful treatment of relatively small lung malignancies with a high rate of complete response and acceptable morbidity, and have suggested that the technique could represent a viable alternate or complementary treatment method for patients with non-small cell lung cancer or lung metastases of favorable histotypes who are not candidates for surgical resection. This article gives an overview of lung RF ablation, discussing experimental animal findings, rationale for clinical application, technique and methodology, clinical results, and complications.",
keywords = "Lung neoplasms, Lung neoplasms, metastases, Lung neoplasms, therapy, Radiofrequency ablation",
author = "Riccardo Lencioni and Laura Crocetti and Roberto Cioni and Alfredo Mussi and Gabriella Fontanini and Marcello Ambrogi and Chiara Franchini and Dania Cioni and Olivia Fanucchi and Raffaello Gemignani and Rubia Baldassarri and Angeletti, {Carlo Alberto} and Carlo Bartolozzi",
year = "2004",
month = "11",
doi = "10.1007/s00270-004-0008-6",
language = "English (US)",
volume = "27",
pages = "581--590",
journal = "CardioVascular and Interventional Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Radiofrequency ablation of lung malignancies

T2 - Where do we stand?

AU - Lencioni, Riccardo

AU - Crocetti, Laura

AU - Cioni, Roberto

AU - Mussi, Alfredo

AU - Fontanini, Gabriella

AU - Ambrogi, Marcello

AU - Franchini, Chiara

AU - Cioni, Dania

AU - Fanucchi, Olivia

AU - Gemignani, Raffaello

AU - Baldassarri, Rubia

AU - Angeletti, Carlo Alberto

AU - Bartolozzi, Carlo

PY - 2004/11

Y1 - 2004/11

N2 - Percutaneous radiofrequency (RF) ablation is a minimally invasive technique used to treat solid tumors. Because of its ability to produce large volumes of coagulation necrosis in a controlled fashion, this technique has gained acceptance as a viable therapeutic option for unresectable liver malignancies. Recently, investigation has been focused on the clinical application of RF ablation in the treatment of lung malignancies. In theory, lung tumors are well suited to RF ablation because the surrounding air in adjacent normal parenchyma provides an insulating effect, thus facilitating energy concentration within the tumor tissue. Experimental studies in rabbits have confirmed that lung RF ablation can be safely and effectively performed via a percutaneous, transthoracic approach, and have prompted the start of clinical investigation. Pilot clinical studies have shown that RF ablation enables successful treatment of relatively small lung malignancies with a high rate of complete response and acceptable morbidity, and have suggested that the technique could represent a viable alternate or complementary treatment method for patients with non-small cell lung cancer or lung metastases of favorable histotypes who are not candidates for surgical resection. This article gives an overview of lung RF ablation, discussing experimental animal findings, rationale for clinical application, technique and methodology, clinical results, and complications.

AB - Percutaneous radiofrequency (RF) ablation is a minimally invasive technique used to treat solid tumors. Because of its ability to produce large volumes of coagulation necrosis in a controlled fashion, this technique has gained acceptance as a viable therapeutic option for unresectable liver malignancies. Recently, investigation has been focused on the clinical application of RF ablation in the treatment of lung malignancies. In theory, lung tumors are well suited to RF ablation because the surrounding air in adjacent normal parenchyma provides an insulating effect, thus facilitating energy concentration within the tumor tissue. Experimental studies in rabbits have confirmed that lung RF ablation can be safely and effectively performed via a percutaneous, transthoracic approach, and have prompted the start of clinical investigation. Pilot clinical studies have shown that RF ablation enables successful treatment of relatively small lung malignancies with a high rate of complete response and acceptable morbidity, and have suggested that the technique could represent a viable alternate or complementary treatment method for patients with non-small cell lung cancer or lung metastases of favorable histotypes who are not candidates for surgical resection. This article gives an overview of lung RF ablation, discussing experimental animal findings, rationale for clinical application, technique and methodology, clinical results, and complications.

KW - Lung neoplasms

KW - Lung neoplasms, metastases

KW - Lung neoplasms, therapy

KW - Radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=19944430020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944430020&partnerID=8YFLogxK

U2 - 10.1007/s00270-004-0008-6

DO - 10.1007/s00270-004-0008-6

M3 - Article

C2 - 15578133

AN - SCOPUS:19944430020

VL - 27

SP - 581

EP - 590

JO - CardioVascular and Interventional Radiology

JF - CardioVascular and Interventional Radiology

SN - 7415-5101

IS - 6

ER -